Antimicrobial Agents and Chemotherapy · 2011 · 51 citations · 10 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial PharmacologyAntimicrobial PharmacotherapyMedical MicrobiologyAntibacterial PharmacologyBacterial BiofilmsBiofilm Formation In InfectionBiofilm-associated PathogenesisMicrobial BiofilmsPulmonary InfectionsAnti-biofilm StrategiesBacterial Biofilm ControlChronic Pseudomonas Aeruginosa InfectionLung Function DeclineRespiratory Bacterial Infections Treatment
In cystic fibrosis patients, chronic lung infection with Pseudomonas aeruginosa and the associated decline in lung function are the major cause of mortality. In this report, we show that pyocin S2 displays potent activity against P. aeruginosa biofilms, thus representing a potentially improved therapeutic option. Using an invertebrate model of P. aeruginosa infection, we also show that pyocin S2 is highly active in vivo.
10
A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance
Thien‐Fah Mah, Betsey Pitts, Brett J. Pellock et al. · Nature · 2003 · 1.2K citations
Sachiko Miyata, Monika Casey, Dara W. Frank et al. · Infection and Immunity · 2003 · 261 citations · Full text